Could an iron scavenger slow ALS? small trial tests deferiprone
NCT ID NCT02164253
First seen Feb 23, 2026 · Last updated May 07, 2026 · Updated 10 times
Summary
This study tested a drug called deferiprone in 23 people with ALS (Lou Gehrig's disease). The drug works by removing extra iron from the brain, which may help protect nerve cells. The goal was to see if the drug is safe and if it can slow down the disease's progression. Participants took the drug for several months, and researchers measured changes in muscle function and daily living skills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Roger Salengro, CHRU de Lille
Lille, 59000, France
Conditions
Explore the condition pages connected to this study.